EVALUATION OF COUGH SUPPOSED TO BE CAUSED BY ALLERGY OR ALLERGY-LIKE DISEASES

• Published in: JIBI INKOKA TEMBO Vol. 42; no. 1; pp. 35 - 38
• Main Authors: Muroi, Masahiko, Kamada, Hideo, Ito, Fumihide
• Format: Journal Article
• Language: Japanese
• Published: Society of Oto-rhino-laryngology Tokyo 1999; 耳鼻咽喉科展望会
• Subjects: allergy-like reactions; cough; immediate allergy attack; アレルギー類似反応; 即時型アレルギー; 咳嗽発作
• ISSN: 0386-9687; 1883-6429
• DOI: 10.11453/orltokyo1958.42.35

Diseases which cause hyperactivity limited to the pharynx, larynx and trachea are unknown. Diagnostic treatments were given to 16 patients who complained of a persistent non-infectious cough. The patients received 1 mg of emedastine difumarate (Remicut (R) ) and 0.2 mg of betamethasone (Rinderon (R) ) twice a day. A nasal aerosol of beclomethasone dipropionate (Beconase (R) ) was added if necessary. Three weeks after the initial treatment, all the patients showed moderate or better than moderate improvement. Of 16 patients, 13 (81.3%) showed remarkable improvement. Antibodies against general inhalation antigens were examined using radioallergosorbent tests (RAST). There was no significant difference in the improvement rate between positive and negative patients. An immediate allergy attack or allergy-like reactions may increase reactivity of the pharynx, larynx and trachea.